Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
20
Number of overlapping holdings
23.8%
% of WDNA's 90 holdings also in BBP
32.8%
% of BBP's 65 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 1.9% | 2.1% | 1.9% |
|
BRIDGEBIO PHARMA, INC. | 2.4% | 1.9% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.8% | 1.7% | 1.7% |
|
AMGEN INC | 1.7% | 2.0% | 1.7% |
|
ALNYLAM PHARMACEUTICALS INC | 1.6% | 1.6% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to BBP
|
NATERA INC | 3.7% |
|
TWIST BIOSCIENCE CORP. | 3.3% |
 |
NOVOZYMES A/S-B SHARES | 2.9% |
|
ELI LILLY & CO | 2.7% |
|
VERICEL CORPORATION | 2.6% |
|
VERACYTE INC | 2.1% |
 |
NOVARTIS AG | 1.7% |
|
BRISTOL-MYERS SQUIBB CO | 1.5% |
|
LABCORP HOLDINGS | 1.5% |
|
DUPONT DE NEMOURS INC | 1.5% |
WDNA Underweight Relative to BBP
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
BEIGENE LTD. SPONSORED ADR | -2.3% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -2.2% |
|
SAGE THERAPEUTICS INC | -2.2% |
|
AXSOME THERAPEUTICS, INC. | -2.1% |
|
SPRINGWORKS THERAPEUTICS, INC. | -2.1% |
|
HALOZYME THERAPEUTICS INC | -2.1% |
|
TG THERAPEUTICS INC | -2.1% |
|
ASCENDIS PHARMA A/S | -1.8% |
|
PTC THERAPEUTICS INC | -1.8% |